PL1687319T3 - Pochodne kwasu fosfinowego - Google Patents

Pochodne kwasu fosfinowego

Info

Publication number
PL1687319T3
PL1687319T3 PL04819605T PL04819605T PL1687319T3 PL 1687319 T3 PL1687319 T3 PL 1687319T3 PL 04819605 T PL04819605 T PL 04819605T PL 04819605 T PL04819605 T PL 04819605T PL 1687319 T3 PL1687319 T3 PL 1687319T3
Authority
PL
Poland
Prior art keywords
acid derivatives
phosphinic acid
pharmaceuticals
preparation
pharmaceutical compositions
Prior art date
Application number
PL04819605T
Other languages
English (en)
Inventor
Wolfgang Froestl
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL1687319T3 publication Critical patent/PL1687319T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Feed For Specific Animals (AREA)
PL04819605T 2003-11-21 2004-11-19 Pochodne kwasu fosfinowego PL1687319T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0327186.3A GB0327186D0 (en) 2003-11-21 2003-11-21 Organic compounds
EP04819605A EP1687319B1 (en) 2003-11-21 2004-11-19 Phosphinic acid derivatives
PCT/EP2004/013177 WO2005054259A1 (en) 2003-11-21 2004-11-19 Phosphinic acid derivatives

Publications (1)

Publication Number Publication Date
PL1687319T3 true PL1687319T3 (pl) 2010-08-31

Family

ID=29764265

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04819605T PL1687319T3 (pl) 2003-11-21 2004-11-19 Pochodne kwasu fosfinowego

Country Status (17)

Country Link
US (1) US7498319B2 (pl)
EP (1) EP1687319B1 (pl)
JP (1) JP4478156B2 (pl)
KR (1) KR100807894B1 (pl)
CN (1) CN1882598B (pl)
AT (1) ATE460421T1 (pl)
AU (1) AU2004295060B2 (pl)
BR (1) BRPI0416226A (pl)
CA (1) CA2545589C (pl)
DE (1) DE602004025965D1 (pl)
ES (1) ES2341254T3 (pl)
GB (1) GB0327186D0 (pl)
MX (1) MXPA06005704A (pl)
PL (1) PL1687319T3 (pl)
PT (1) PT1687319E (pl)
RU (1) RU2368616C2 (pl)
WO (1) WO2005054259A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109125331A (zh) * 2018-09-13 2019-01-04 大连医科大学附属第二医院 Gabab受体拮抗剂在阻断trek-1通道方面的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8820266D0 (en) * 1988-08-26 1988-09-28 Smith Kline French Lab Compounds
IL114631A (en) * 1990-06-22 1998-12-06 Novartis Ag Anti-epileptic compositions containing gabab- antagonistic compounds
EP0543780A3 (en) * 1991-11-21 1993-09-01 Ciba-Geigy Ag Novel aminoalkanephosphinic acids and their salts
AU662404B2 (en) * 1992-05-08 1995-08-31 Novartis Ag Novel N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids
SE9603408D0 (sv) * 1996-09-18 1996-09-18 Astra Ab Medical use

Also Published As

Publication number Publication date
CA2545589A1 (en) 2005-06-16
US20070259835A1 (en) 2007-11-08
RU2368616C2 (ru) 2009-09-27
CN1882598A (zh) 2006-12-20
ES2341254T3 (es) 2010-06-17
PT1687319E (pt) 2010-06-04
EP1687319A1 (en) 2006-08-09
CA2545589C (en) 2013-03-12
EP1687319B1 (en) 2010-03-10
RU2006121648A (ru) 2008-01-10
BRPI0416226A (pt) 2007-01-02
GB0327186D0 (en) 2003-12-24
CN1882598B (zh) 2010-06-16
ATE460421T1 (de) 2010-03-15
AU2004295060A1 (en) 2005-06-16
KR100807894B1 (ko) 2008-02-27
US7498319B2 (en) 2009-03-03
KR20060097037A (ko) 2006-09-13
AU2004295060B2 (en) 2007-08-30
MXPA06005704A (es) 2006-08-17
JP2007513088A (ja) 2007-05-24
JP4478156B2 (ja) 2010-06-09
DE602004025965D1 (en) 2010-04-22
WO2005054259A1 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
MXPA05012025A (es) Imidazo y tiazolopiridinas como inhibidores de cinasa jak3.
MXPA05012026A (es) Compuestos de azaindol como inhibidores de cinasa.
TW200505837A (en) Novel compounds
TW200519075A (en) Novel compounds
TW200508214A (en) Novel compounds
NO20051102L (no) Sulfonylamino-eddiksyre-derivater
EP2415760A3 (en) CCR-9 antagonists
WO2004092135A3 (en) Substituted benzosulphonamide as potentiators of glutamate receptors
TW200639173A (en) Substituted pyrazolopyridines, compositions containing same, manufacturing process therefor and use thereof
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
TW200510344A (en) Aryl-heteroaromatic products, compositions comprising them and use
ZA200604410B (en) Imidazole derivatives, processes for preparing them and their uses
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL164440A0 (en) New pharmaceutical composition containing fibanserin polymorph a
TW200604197A (en) New compounds
TW200716605A (en) 2,6-quinolinyl derivatives, processes for preparing them and their uses
MX2009000768A (es) Lactamas macrociclicas.
WO2007065595A3 (en) Xanthine derivatives, processes for preparing them and their uses
TW200630343A (en) 2-Alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
SE0300457D0 (sv) Novel compounds
TW200503783A (en) Oral pharmaceutical preparation for proton pump antagonists
DE602004025965D1 (en) Phosphinsäurederivate
MX2009005182A (es) Derivados de 2-hidroxi-1,3-diamino-propano.
TW200640858A (en) Substituted pyrroles, compositions containing them, method of manufacture and use